751. Synthesis and Evaluation of Galloyl Conjugates of Flavanones as BMP-2 Upregulators with Promising Bone Anabolic and Fracture Healing Properties.
- Author
-
Raj Pandey A, Rai D, Singh SP, Tripathi AK, Sardar A, Ansari A, Mishra A, Bhagwati S, Bhatta RS, Siddiqi MI, Chattopadhyay N, Trivedi R, and Sashidhara KV
- Subjects
- Animals, Bone Morphogenetic Protein 2 genetics, Bone and Bones drug effects, Cell Differentiation drug effects, Gene Expression Regulation drug effects, Humans, Molecular Structure, Osteoblasts drug effects, Osteoporosis, Rats, Structure-Activity Relationship, Up-Regulation drug effects, Bone Morphogenetic Protein 2 metabolism, Bone and Bones metabolism, Flavanones chemical synthesis, Flavanones pharmacology, Fractures, Bone drug therapy
- Abstract
The molecular hybridization concept led us to design a series of galloyl conjugates of flavanones that have potent osteoblast differentiation ability in vitro and promote bone formation in vivo . An array of in vitro studies, especially gene expression of osteogenic markers, evinced compound 5e as the most potent bone anabolic agent, found to be active at 1 pM, which was then further assessed for its osteogenic potential in vivo . From in vivo studies on rat calvaria and a fracture defect model, we inferred that compound 5e , at an oral dose of 5 mg/(kg day), increased the expression of osteogenic genes (RUNX2, BMP-2, Col1, and OCN) and the bone formation rate and significantly promoted bone regeneration at the fracture site, as evidenced by the increased bone volume/tissue fraction compared with vehicle-treated rats. Furthermore, structure-activity relationship studies and pharmacokinetic studies suggest 5e as a potential bone anabolic lead for future osteoporosis drug development.
- Published
- 2021
- Full Text
- View/download PDF